Roivant Sciences (ROIV) Short term Debt (2022 - 2024)

Roivant Sciences has reported Short term Debt for 3 years, with the latest figure at $12.0 million in Q2 2024.

• For the quarter ending Q2 2024, Short term Debt fell 72.98% year-over-year to $12.0 million; the trailing twelve-month figure through Jun 2024 stood at $12.0 million (down 72.98% YoY), and the FY2024 full-year result was $12.0 million, down 70.53% from the prior year.
• Short term Debt for Q2 2024 stood at $12.0 million, roughly flat from $12.0 million in the prior quarter.
• The five-year high for Short term Debt was $49.0 million in Q3 2023, with the low at $12.0 million in Q1 2024.
• Historically, Short term Debt has averaged $34.5 million across 3 years, with a median of $37.7 million in 2022.
• Annual changes were most pronounced in 2023 — Short term Debt surged 37.04% — and 2024, when it plunged 72.98%.
• Roivant Sciences' Short term Debt stood at $37.7 million in 2022, then rose by 21.16% to $45.7 million in 2023, then plunged by 73.75% to $12.0 million in 2024.
• The last three Short term Debt figures came in at $12.0 million (Q2 2024), $12.0 million (Q1 2024), and $45.7 million (Q4 2023), per Business Quant data.